Optomed Oyj Logo

Optomed Oyj

ISIN: FI4000410881 | Ticker: OPTOMED | LEI: 7437009IVYWGEE4S7B77
Sector: Health CareSub-Industry: Health Care Equipment
Country: Finland

About Optomed Oyj

Company Description

Optomed is a Finnish medical technology company and a leading provider of handheld fundus cameras. Optomed combines handheld fundus cameras with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye diseases such as rapidly increasing diabetic retinopathy.

Optomed was founded in Oulu, Finland in 2004 by Seppo Kopsala Optomed’s CEO, with the vision to design and produce a smaller and more affordable fundus camera than traditionally used desktop cameras, which would improve the efficiency of the eye screening of diabetics. In the early years, the operations were focused on research and development with a long-term perspective and sales activities were limited.

Served area

Worldwide

Headquarters

Yrttipellontie 1, 90230 Oulu – Finland

Financial statements

Download as Excel
Line item in (eur) 01.01.2019 01.01.2020 01.01.2021 01.01.2022 01.01.2023
Assets N/A 39,611,000.00 31,073,000.00 28,998,000.00 31,300,000.00
Noncurrent Assets N/A 14,151,000.00 14,289,000.00 14,626,000.00 15,210,000.00
Property Plant And Equipment N/A 406,000.00 359,000.00 433,000.00 852,000.00
Goodwill N/A 4,256,000.00 4,256,000.00 4,256,000.00 4,256,000.00
Intangible Assets Under Development N/A 5,218,000.00 5,667,000.00 6,338,000.00 6,562,000.00
Other Intangible Assets N/A 519,000.00 485,000.00 358,000.00 379,000.00
Deferred Tax Assets N/A 8,000.00 11,000.00 13,000.00 15,000.00
Current Assets N/A 25,459,000.00 16,784,000.00 14,371,000.00 16,090,000.00
Inventories N/A 2,468,000.00 2,539,000.00 2,936,000.00 2,998,000.00
Current Trade Receivables N/A 2,897,000.00 2,639,000.00 3,658,000.00 3,556,000.00
Other Current Receivables N/A 1,228,000.00 998,000.00 973,000.00 1,012,000.00
Cash and cash equivalents 2,000,000.00 18,866,000.00 10,608,000.00 6,804,000.00 8,524,000.00
Equity And Liabilities N/A 39,611,000.00 31,073,000.00 28,998,000.00 31,300,000.00
Equity 5,552,000.00 22,637,000.00 20,073,000.00 17,052,000.00 20,342,000.00
Issued Capital N/A 80,000.00 80,000.00 80,000.00 80,000.00
Retained Earnings Profit Loss For Reporting Period N/A N/A N/A -4,249,000.00 -5,472,000.00
Retained Earnings Excluding Profit Loss For Reporting Period N/A N/A N/A -17,721,000.00 -21,717,000.00
Share Premium N/A 504,000.00 504,000.00 504,000.00 504,000.00
Liabilities N/A 16,973,000.00 11,001,000.00 11,946,000.00 10,957,000.00
Noncurrent Liabilities N/A 9,416,000.00 7,512,000.00 7,034,000.00 5,731,000.00
Deferred Tax Liabilities N/A 616,000.00 540,000.00 463,000.00 387,000.00
Longterm Borrowings N/A 5,104,000.00 3,520,000.00 3,813,000.00 3,380,000.00
Current Liabilities N/A 7,557,000.00 3,489,000.00 4,912,000.00 5,227,000.00
Trade And Other Current Payables To Trade Suppliers N/A 1,667,000.00 595,000.00 944,000.00 869,000.00
Other Current Payables N/A 3,650,000.00 2,141,000.00 2,308,000.00 2,959,000.00
Line item in (eur) 01.01.2019/
01.01.2020
01.01.2020/
01.01.2021
01.01.2021/
01.01.2022
01.01.2022/
01.01.2023
Revenue 14,977,000.00 13,011,000.00 14,850,000.00 14,660,000.00
Other Income 254,000.00 157,000.00 810,000.00 857,000.00
Employee Benefits Expense 7,299,000.00 7,319,000.00 8,702,000.00 8,827,000.00
Depreciation Amortisation And Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss 2,261,000.00 2,173,000.00 2,778,000.00 3,145,000.00
Other Expense By Nature 2,980,000.00 2,369,000.00 3,858,000.00 3,193,000.00
Profit Loss From Operating Activities -2,596,000.00 -2,906,000.00 -4,780,000.00 -5,097,000.00
Finance Income 8,000.00 452,000.00 715,000.00 569,000.00
Finance Costs 365,000.00 794,000.00 263,000.00 1,024,000.00
Profit Loss Before Tax -2,952,000.00 -3,247,000.00 -4,327,000.00 -5,551,000.00
Income Tax Expense Continuing Operations -77,000.00 -70,000.00 -78,000.00 -79,000.00
Profit (loss) -2,875,000.00 -3,177,000.00 -4,249,000.00 -5,472,000.00
Profit Loss Attributable To Owners Of Parent -2,875,000.00 -3,177,000.00 -4,249,000.00 -5,472,000.00
Line item in (eur) 01.01.2019 01.01.2020 01.01.2021 01.01.2022 01.01.2023
Profit (loss) N/A -2,875,000.00 -3,177,000.00 -4,249,000.00 -5,472,000.00
Adjustments For Decrease Increase In Inventories N/A -1,346,000.00 -83,000.00 -340,000.00 -68,000.00
Adjustments For Depreciation And Amortisation Expense N/A 2,261,000.00 2,173,000.00 N/A N/A
Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss N/A N/A 2,173,000.00 2,689,000.00 3,145,000.00
Other Adjustments For Noncash Items N/A 466,000.00 284,000.00 454,000.00 -770,000.00
Cash Flows From Used In Operations N/A 475,000.00 -2,367,000.00 -2,811,000.00 -2,171,000.00
Interest Paid Classified As Operating Activities N/A 202,000.00 75,000.00 66,000.00 76,000.00
Interest Received Classified As Operating Activities N/A 24,000.00 366,000.00 1,000.00 0.00
Cash Flows From Used In Operating Activities N/A 161,000.00 -2,801,000.00 -2,940,000.00 -2,370,000.00
Purchase Of Property Plant And Equipment Classified As Investing Activities N/A 260,000.00 268,000.00 462,000.00 780,000.00
Purchase Of Intangible Assets Classified As Investing Activities N/A 1,175,000.00 1,553,000.00 2,112,000.00 2,249,000.00
Cash Flows From Used In Investing Activities N/A -1,434,000.00 -1,820,000.00 -2,574,000.00 -3,029,000.00
Proceeds From Issuing Shares N/A 23,000,000.00 92,000.00 1,012,000.00 9,012,000.00
Proceeds From Borrowings Classified As Financing Activities N/A 176,000.00 -167,000.00 1,366,000.00 0.00
Repayments Of Borrowings Classified As Financing Activities N/A 460,000.00 3,233,000.00 327,000.00 912,000.00
Payments Of Lease Liabilities Classified As Financing Activities N/A 385,000.00 390,000.00 414,000.00 415,000.00
Cash Flows From Used In Financing Activities N/A 18,123,000.00 -3,698,000.00 1,637,000.00 7,003,000.00
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes N/A 16,849,000.00 -8,319,000.00 -3,876,000.00 1,605,000.00
Effect Of Exchange Rate Changes On Cash And Cash Equivalents N/A 17,000.00 61,000.00 73,000.00 115,000.00
Cash and cash equivalents 2,000,000.00 18,866,000.00 10,608,000.00 6,804,000.00 8,524,000.00

Please note that some sums might not add up.

Filings & Publications

2022

Report
Q1
H1
Q3
FY
Consolidated Report
ENG / FIN
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2021

Report
Q1
H1
Q3
FY
Consolidated Report
FIN / ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2020

Report
Q1
H1
Q3
FY
Consolidated Report
FIN / ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

Insider Trades

Sign up and we will give you access!

Capital markets information

ISIN

FI4000410881

LEI

7437009IVYWGEE4S7B77

Sector

Health Care

Industry Group

Health Care Equipment & Services

Industry

Health Care Equipment & Supplies

Sub-Industry

Health Care Equipment

Listed Stock Exchange

Nasdaq Helsinki

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.